Evidence map›Paper›PMID 30192228›Full record

ArticleeLife2018

Defective RNA polymerase III is negatively regulated by the SUMO-Ubiquitin-Cdc48 pathway.

Zheng Wang, Catherine Wu, Aaron Aslanian, John R Yates, Tony Hunter

Abstract read
In one paragraph

Article in eLife, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. RNA Polymerases I and III in development and disease.Seminars in cell & developmental biology · 2023
    Review
  5. Biallelic pathogenic variants inFrontiers in neurology · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zheng WangMolecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, United States.
Catherine WuMolecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, United States.
Aaron AslanianMolecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, United States.
John R YatesThe Scripps Research Institute, La Jolla, United States.
Tony HunterMolecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, United States.ORCID 0000-0002-7691-6993

Funding

Viral Vector Core (VVC)P30CA014195 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI Ye Zheng · 1985 to 2026
$82.8M
ZDS2P REGULATES SWE1P-DEPENDENT POLARIZED CELL GROWTH IN S CEREVISIAEP41RR011823 · NCRR · UNIVERSITY OF WASHINGTON · PI DAVIS, TRACY · 1996 to 2011
$24.7M
TrainingP41GM103533 · NIGMS · UNIVERSITY OF WASHINGTON · PI MACCOSS, MICHAEL · 2012 to 2021
$20.7M
SOMATIC CELL CYCLE REGULATION BY PHOSPHORYLATIONR01CA080100 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI HUNTER, TONY R. · 1999 to 2018
$13.1M
SIGNAL TRANSDUCTION BY TYROSINE PHOSPHORYLATIONR01CA082683 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI HUNTER, TONY R. · 1999 to 2019
$12.2M
NCI NIH HHS P30 CA014195NCI NIH HHS R01 CA080100NCI NIH HHS R01 CA082683NCRR NIH HHS 5P41RR011823-17NCRR NIH HHS P41 RR011823NIGMS NIH HHS 8P41GM103533-17NIGMS NIH HHS P41 GM103533NIH HHS CA014195NIH HHS CA080100NIH HHS CA082683
6 · The paper itself

Abstract

Transcription by RNA polymerase III (Pol III) is an essential cellular process, and mutations in Pol III can cause neurodegenerative disease in humans. However, in contrast to Pol II transcription, which has been extensively studied, the knowledge of how Pol III is regulated is very limited. We report here that in budding yeast,

Indexed as

Signal TransductionAmino Acid SequenceChromatinGenes, SuppressorGenetic TestingModels, BiologicalMutant ProteinsMutationPhenotypeRNA Polymerase IIISaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSmall Ubiquitin-Related Modifier ProteinsSumoylationUbiquitinUbiquitinationChromatinMutant ProteinsRNA Polymerase IIISaccharomyces cerevisiae ProteinsSmall Ubiquitin-Related Modifier ProteinsUbiquitinValosin Containing Proteinbiochemistrychemical biologychromosomesgene expressionneurodegenerationpost-translational modificationquality controlS. cerevisiaeSUMOtranscriptionUbiquitin

Identifiers

PMID30192228
PMCPMC6128692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.